Literature DB >> 11426825

Expression of Basigin in human fetal, infantile and adult skin and in basal cell carcinoma.

X Chen1, T Kanekura, T Kanzaki.   

Abstract

BACKGROUND: Basigin is a glycosylated transmembrane protein belonging to the immunoglobulin superfamily and is thought to be associated with cell development and differentiation. We investigated the relation between Basigin expression and epidermal development in this study.
METHODS: Basigin expression was immunohistochemically investigated during organogenesis of human skin and in human basal cell carcinoma (BCC).
RESULTS: Human fetal skin showed negative staining at 10 weeks of gestation. At 20 weeks, the cytoplasm and membranes of adnexal germ and hair follicular cells were strongly positive, while epidermal basal cells showed weakly positive staining. After birth, basal cells, suprabasal cells, anagen hair follicular cells and eccrine glandular cells showed positive staining. Membranes of basal cells expressed more Basigin compared to other cell components. Basigin was not detectable in granular cells and telogen hair follicular cells. Sixteen of 30 BCCs were entirely negative for Basigin. However, cells at budding areas of tumor masses were positive in 14 of the 30 BCCs.
CONCLUSIONS: These findings suggest that 1) Basigin is associated with epidermal proliferation and differentiation, 2) most parts of BCCs might be derived from early fetal epidermal basal cells, and 3) that a part, only the budding area of BCCs, has the characteristics of epithelial germ cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11426825     DOI: 10.1034/j.1600-0560.2001.028004184.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  11 in total

1.  CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer.

Authors:  Yi-Jun Xue; Qiang Lu; Zhi-Xi Sun
Journal:  Med Oncol       Date:  2010-05-28       Impact factor: 3.064

Review 2.  Proteolytic activity in the meibomian gland: Implications to health and disease.

Authors:  Pablo Argüeso
Journal:  Exp Eye Res       Date:  2017-03-08       Impact factor: 3.467

3.  CD147 promotes the proliferation, invasiveness, migration and angiogenesis of human lung carcinoma cells.

Authors:  Shaoxing Yang; Fei Qi; Chuanhao Tang; Hong Wang; Haifeng Qin; Xiaoyan Li; Jianjie Li; Weixia Wang; Changyun Zhao; Hongjun Gao
Journal:  Oncol Lett       Date:  2016-12-14       Impact factor: 2.967

Review 4.  Matrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play.

Authors:  Lourdes Chuliá-Peris; Cristina Carreres-Rey; Marta Gabasa; Jordi Alcaraz; Julián Carretero; Javier Pereda
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

5.  The glycosylated IgII extracellular domain of EMMPRIN is implicated in the induction of MMP-2.

Authors:  Adriana Papadimitropoulou; Avgi Mamalaki
Journal:  Mol Cell Biochem       Date:  2013-04-06       Impact factor: 3.396

6.  Extracellular Cyclophilin A Augments Platelet-Dependent Thrombosis and Thromboinflammation.

Authors:  Saskia N I von Ungern-Sternberg; Sebastian Vogel; Britta Walker-Allgaier; Sascha Geue; Andreas Maurer; Anna-Maria Wild; Patrick Münzer; Madhumita Chatterjee; David Heinzmann; Elisabeth Kremmer; Oliver Borst; Patricia Loughran; Alma Zernecke; Matthew D Neal; Timothy R Billiar; Meinrad Gawaz; Peter Seizer
Journal:  Thromb Haemost       Date:  2017-11-30       Impact factor: 5.249

7.  Role of emmprin in endometrial cancer.

Authors:  Keiichiro Nakamura; Junichi Kodama; Atsushi Hongo; Yuji Hiramatsu
Journal:  BMC Cancer       Date:  2012-05-28       Impact factor: 4.430

8.  Loss of CD147 results in impaired epithelial cell differentiation and malformation of the meibomian gland.

Authors:  J Mauris; J Dieckow; S Schob; B Pulli; M P Hatton; S Jeong; A Bauskar; E Gabison; R Nowak; P Argüeso
Journal:  Cell Death Dis       Date:  2015-04-16       Impact factor: 8.469

Review 9.  Repressing CD147 is a novel therapeutic strategy for malignant melanoma.

Authors:  Xing Hu; Juan Su; Youyou Zhou; Xiaoyun Xie; Cong Peng; Zhimin Yuan; Xiang Chen
Journal:  Oncotarget       Date:  2017-04-11

10.  Up-regulated expression of CD147 gene in malignant bone tumor and the possible induction mechanism during osteoclast formation.

Authors:  Suchi Qiao; Chang Liu; Weijie Xu; WuBuLi AZhaTi; Cheng Li; Zhiwei Wang
Journal:  Braz J Med Biol Res       Date:  2018-07-23       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.